Overview Fundamentals API Earnings EOD API Sample Code Pricing

Regulus Therapeutics Inc (RGLS NASDAQ) stock market data APIs

$1.69 0.04(2.4%) as of July 19, 2024
Price chart is built with Anychart

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Regulus Therapeutics Inc Financial Data Overview

108 M
65 466 K
5 000 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RGLS',
Type: 'Common Stock',
Name: 'Regulus Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000R33DR2',
CIK: '1505512',
EmployerIdNumber: '26-4738379',
FiscalYearEnd: 'December',
IPODate: '2012-10-04',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Regulus Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 000 K
  • EBITDA -32 306 000
  • Earnings Per Share -1.45
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Regulus Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.22

Get Regulus Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?